Alessandro Minisini

8PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma.

|Jun 26, 2026
Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?

|Jun 12, 2026
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

|May 27, 2026
New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma.

|Sep 27, 2022
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.

Joan Albanell, José Manuel Pérez-García, Miguel Gil-Gil

|Aug 04, 2020
Immunotherapy for older patients with melanoma: From darkness to light?

Donatella Iacono, Maria Grazia Vitale, Debora Basile

Pageof 2

Frequent Collaborators

4 joint publications

Paolo Fava

4 joint publications

Jacopo Pigozzo

4 joint publications

Gabriele Roccuzzo

4 joint publications

Andrea Spagnoletti